Publications by authors named "Dyhia Kersani"

The main cause of failure of angioplasty stenting is restenosis due to neointimal hyperplasia, a too high proliferation of smooth muscle cells (SMC). The local and sustained delivery of selective pleiotropic drugs to limit SMC proliferation seems to be the hopeful solution to minimize this post surgery complication. The aim of this study is to develop a stent covered by nanofibers (NFs) produced by electrospinning, loaded with simvastatin (SV), a drug commonly used for restenosis prevention.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Dyhia Kersani"

  • - Dyhia Kersani's research focuses on biomedical applications, particularly in the development of innovative drug delivery systems to prevent restenosis following angioplasty stenting.
  • - One key study involves creating stent coatings using electrospun chitosan/poly-cyclodextrin nanofibers infused with simvastatin, aimed at delivering the drug locally to inhibit smooth muscle cell proliferation.
  • - The findings indicate that the sustained release of simvastatin from the nanofibers offers a promising strategy to mitigate neointimal hyperplasia, a significant cause of stenting failure, thereby improving patient outcomes post-surgery.